首页 > 最新文献

American journal of therapeutics最新文献

英文 中文
Percutaneous Versus Surgical Cutdown Access for Endovascular Aneurysm Repair: A Meta-Analysis of Randomized Controlled Trials. 血管内动脉瘤修复的经皮切口与手术切口:随机对照试验的荟萃分析。
IF 2.5 4区 医学 Q2 PHARMACOLOGY & PHARMACY Pub Date : 2026-01-01 Epub Date: 2025-05-28 DOI: 10.1097/MJT.0000000000001961
Muhammad Abdullah Ali, Fazia Khattak, Saqib Hayat Khan, Abdullah Afridi, Umama Alam, Sufyan Shahid, Allahdad Khan, Zaryab Bacha
{"title":"Percutaneous Versus Surgical Cutdown Access for Endovascular Aneurysm Repair: A Meta-Analysis of Randomized Controlled Trials.","authors":"Muhammad Abdullah Ali, Fazia Khattak, Saqib Hayat Khan, Abdullah Afridi, Umama Alam, Sufyan Shahid, Allahdad Khan, Zaryab Bacha","doi":"10.1097/MJT.0000000000001961","DOIUrl":"10.1097/MJT.0000000000001961","url":null,"abstract":"","PeriodicalId":7760,"journal":{"name":"American journal of therapeutics","volume":" ","pages":"e107-e110"},"PeriodicalIF":2.5,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144172367","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Decrease of PD-L1 Expression Affects the Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients With Lung Squamous Cell Carcinoma. PD-L1表达降低影响肺鳞癌患者表皮生长因子受体酪氨酸激酶抑制剂的疗效
IF 2.5 4区 医学 Q2 PHARMACOLOGY & PHARMACY Pub Date : 2026-01-01 Epub Date: 2025-04-17 DOI: 10.1097/MJT.0000000000001965
Yin Jie, Du Mingzhan, Gong Yinhua, Shen Dan
{"title":"The Decrease of PD-L1 Expression Affects the Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients With Lung Squamous Cell Carcinoma.","authors":"Yin Jie, Du Mingzhan, Gong Yinhua, Shen Dan","doi":"10.1097/MJT.0000000000001965","DOIUrl":"10.1097/MJT.0000000000001965","url":null,"abstract":"","PeriodicalId":7760,"journal":{"name":"American journal of therapeutics","volume":" ","pages":"e105-e107"},"PeriodicalIF":2.5,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12767625/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143960344","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Resistance to Antibiotics, Complications, and Mortality of Infective Endocarditis in a Consecutive Cohort of 178 Cases. 178例感染性心内膜炎患者的抗生素耐药性、并发症和死亡率
IF 2.5 4区 医学 Q2 PHARMACOLOGY & PHARMACY Pub Date : 2026-01-01 DOI: 10.1097/MJT.0000000000002094
Alexandru Covaciu, Elena Bobescu, Valentina Benza, Elena Lorena Pepine, Madalina Ivascu, Andreea Amalia Tomulescu, Emanuel Cojocariu, Lilia Aida Mahjoub, Nicoleta Cojocaru, Liliana Rogozea, Lorena Dima, Christian Gabriel Strempel, Horatiu Rus

Background: Infective endocarditis is a severe cardiac infection disease with high morbidity and mortality, remained largely unchanged over the past 2 decades with an increased incidence in the last years.

Study question: Was to evaluate the main causes of increased incidence and antibiotic resistance and the role of biomarkers in infective endocarditis.

Study design: Patients with infective endocarditis admitted in Cardiology Department were evaluated regarding the annual incidence and characteristics in the last 8 years, to identify the causes of the increased incidence of this disease.

Measures and outcomes: We enrolled 178 patients diagnosed with infective endocarditis admitted in hospital in the last 8 years. The data included patient's demographic data, medical history, presence of preexisting risk, or associated systemic diseases.

Results and discussion: Infective endocarditis was diagnosed twice as frequently in urban areas with two-thirds of patients being male and 4 of 5 patients being older than 60 years. The most common disease associated was previous valvopathies and the most affected aortic native valve in 1 of 5 cases. Inflammation markers were predictive for diagnosis, complication, and prognosis in patients with IE. The highest frequencies pathogens were Staphylococcus spp., Enterococcus spp., and Streptococcus spp. Two-thirds of patients needed reserve antibiotics such as glycopeptides and/or carbapenems because of antibiotic resistance. The predictors for in-hospital mortality were the following: old age, heart and renal failure, markers of organ dysfunction, persistence of infection, and high inflammatory markers.

Conclusions: Infective endocarditis was diagnosed more frequently in urban areas, in male, and those aged older than 60 years. Previous valvopathies was most common associated disease, and aortic native valve was the most affected. Persistent infection and inflammation were predictors for bad prognosis in patients with infective endocarditis. The top 3 highest frequencies pathogens were Staphylococcus spp., Enterococcus spp., and Streptococcus spp., and an increase in antibiotic resistance has been recorded.

背景:感染性心内膜炎是一种严重的心脏感染性疾病,发病率和死亡率高,在过去的20年里基本没有变化,但近年来发病率有所增加。研究问题:评估感染性心内膜炎发病率和抗生素耐药性增加的主要原因以及生物标志物的作用。研究设计:对心内科收治的感染性心内膜炎患者近8年的年发病率及特点进行评估,以确定该疾病发病率增加的原因。测量方法和结果:我们纳入了178例在过去8年中确诊为感染性心内膜炎的住院患者。数据包括患者的人口统计数据、病史、既往存在的风险或相关的全身性疾病。结果与讨论:感染性心内膜炎在城市地区的诊断频率是城市地区的两倍,三分之二的患者为男性,五分之四的患者年龄在60岁以上。最常见的相关疾病是既往瓣膜病变,5例中有1例最受影响的主动脉瓣。炎症标志物可预测IE患者的诊断、并发症和预后。常见致病菌为葡萄球菌、肠球菌和链球菌,三分之二的患者因耐药需要使用糖肽类和/或碳青霉烯类等储备抗生素。住院死亡率的预测因子如下:老年、心脏和肾功能衰竭、器官功能障碍标志物、感染持续性和高炎症标志物。结论:感染性心内膜炎在城市地区、男性和年龄大于60岁的人群中更为常见。既往瓣膜病变是最常见的相关疾病,主动脉原瓣膜受影响最大。持续性感染和炎症是感染性心内膜炎患者不良预后的预测因素。常见病原菌前3位分别为葡萄球菌、肠球菌和链球菌,且耐药性呈上升趋势。
{"title":"Resistance to Antibiotics, Complications, and Mortality of Infective Endocarditis in a Consecutive Cohort of 178 Cases.","authors":"Alexandru Covaciu, Elena Bobescu, Valentina Benza, Elena Lorena Pepine, Madalina Ivascu, Andreea Amalia Tomulescu, Emanuel Cojocariu, Lilia Aida Mahjoub, Nicoleta Cojocaru, Liliana Rogozea, Lorena Dima, Christian Gabriel Strempel, Horatiu Rus","doi":"10.1097/MJT.0000000000002094","DOIUrl":"https://doi.org/10.1097/MJT.0000000000002094","url":null,"abstract":"<p><strong>Background: </strong>Infective endocarditis is a severe cardiac infection disease with high morbidity and mortality, remained largely unchanged over the past 2 decades with an increased incidence in the last years.</p><p><strong>Study question: </strong>Was to evaluate the main causes of increased incidence and antibiotic resistance and the role of biomarkers in infective endocarditis.</p><p><strong>Study design: </strong>Patients with infective endocarditis admitted in Cardiology Department were evaluated regarding the annual incidence and characteristics in the last 8 years, to identify the causes of the increased incidence of this disease.</p><p><strong>Measures and outcomes: </strong>We enrolled 178 patients diagnosed with infective endocarditis admitted in hospital in the last 8 years. The data included patient's demographic data, medical history, presence of preexisting risk, or associated systemic diseases.</p><p><strong>Results and discussion: </strong>Infective endocarditis was diagnosed twice as frequently in urban areas with two-thirds of patients being male and 4 of 5 patients being older than 60 years. The most common disease associated was previous valvopathies and the most affected aortic native valve in 1 of 5 cases. Inflammation markers were predictive for diagnosis, complication, and prognosis in patients with IE. The highest frequencies pathogens were Staphylococcus spp., Enterococcus spp., and Streptococcus spp. Two-thirds of patients needed reserve antibiotics such as glycopeptides and/or carbapenems because of antibiotic resistance. The predictors for in-hospital mortality were the following: old age, heart and renal failure, markers of organ dysfunction, persistence of infection, and high inflammatory markers.</p><p><strong>Conclusions: </strong>Infective endocarditis was diagnosed more frequently in urban areas, in male, and those aged older than 60 years. Previous valvopathies was most common associated disease, and aortic native valve was the most affected. Persistent infection and inflammation were predictors for bad prognosis in patients with infective endocarditis. The top 3 highest frequencies pathogens were Staphylococcus spp., Enterococcus spp., and Streptococcus spp., and an increase in antibiotic resistance has been recorded.</p>","PeriodicalId":7760,"journal":{"name":"American journal of therapeutics","volume":"33 1","pages":"e1-e14"},"PeriodicalIF":2.5,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145931779","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Role of GLP-1 Agonists in Psoriatic Arthritis: Erratum. GLP-1激动剂在银屑病关节炎中的作用:勘误。
IF 2.5 4区 医学 Q2 PHARMACOLOGY & PHARMACY Pub Date : 2026-01-01 DOI: 10.1097/MJT.0000000000002083
Nathaniel Gilbert, Halah Alfatlawi, Hajera Amatul-Raheem, Jennifer Delucia, Nezam Altorok
{"title":"The Role of GLP-1 Agonists in Psoriatic Arthritis: Erratum.","authors":"Nathaniel Gilbert, Halah Alfatlawi, Hajera Amatul-Raheem, Jennifer Delucia, Nezam Altorok","doi":"10.1097/MJT.0000000000002083","DOIUrl":"https://doi.org/10.1097/MJT.0000000000002083","url":null,"abstract":"","PeriodicalId":7760,"journal":{"name":"American journal of therapeutics","volume":"33 1","pages":"e119"},"PeriodicalIF":2.5,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145931825","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of SGLT2 Inhibitors and GLP-1 Receptor Agonists on the Risk of Atrial Fibrillation in Patients With Type 2 Diabetes: A Systematic Review and Meta-analysis. SGLT2抑制剂和GLP-1受体激动剂对2型糖尿病患者房颤风险的影响:一项系统综述和荟萃分析
IF 2.5 4区 医学 Q2 PHARMACOLOGY & PHARMACY Pub Date : 2026-01-01 Epub Date: 2025-04-30 DOI: 10.1097/MJT.0000000000001968
Akash Kumar, Mariam Shahabi, Saad Ahmed Waqas, Nisha Kumari, Nimurta Madhwani, Raheel Ahmed, Ram
{"title":"Comparison of SGLT2 Inhibitors and GLP-1 Receptor Agonists on the Risk of Atrial Fibrillation in Patients With Type 2 Diabetes: A Systematic Review and Meta-analysis.","authors":"Akash Kumar, Mariam Shahabi, Saad Ahmed Waqas, Nisha Kumari, Nimurta Madhwani, Raheel Ahmed, Ram","doi":"10.1097/MJT.0000000000001968","DOIUrl":"10.1097/MJT.0000000000001968","url":null,"abstract":"","PeriodicalId":7760,"journal":{"name":"American journal of therapeutics","volume":" ","pages":"e113-e115"},"PeriodicalIF":2.5,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143971454","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Colchicine-Induced Severe Bone Marrow Suppression: Treatment With Platelet Suspensions. 秋水仙碱诱导的严重骨髓抑制:血小板悬浮液治疗。
IF 2.5 4区 医学 Q2 PHARMACOLOGY & PHARMACY Pub Date : 2026-01-01 Epub Date: 2025-12-09 DOI: 10.1097/MJT.0000000000001886
İbrahim Altundağ, Semih Korkut, Aynur Şahin
{"title":"Colchicine-Induced Severe Bone Marrow Suppression: Treatment With Platelet Suspensions.","authors":"İbrahim Altundağ, Semih Korkut, Aynur Şahin","doi":"10.1097/MJT.0000000000001886","DOIUrl":"10.1097/MJT.0000000000001886","url":null,"abstract":"","PeriodicalId":7760,"journal":{"name":"American journal of therapeutics","volume":" ","pages":"e55-e56"},"PeriodicalIF":2.5,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145707000","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy and Safety of Zanubrutinib in B-Cell Malignancies: A Single-Arm Meta-Analysis. 扎鲁替尼治疗b细胞恶性肿瘤的疗效和安全性:一项单臂荟萃分析
IF 2.5 4区 医学 Q2 PHARMACOLOGY & PHARMACY Pub Date : 2026-01-01 DOI: 10.1097/MJT.0000000000001872
Rongrong Chen, Shiquan Yu, Yun Liao, Jiayue Liu, Chunlan Huang
{"title":"Efficacy and Safety of Zanubrutinib in B-Cell Malignancies: A Single-Arm Meta-Analysis.","authors":"Rongrong Chen, Shiquan Yu, Yun Liao, Jiayue Liu, Chunlan Huang","doi":"10.1097/MJT.0000000000001872","DOIUrl":"https://doi.org/10.1097/MJT.0000000000001872","url":null,"abstract":"","PeriodicalId":7760,"journal":{"name":"American journal of therapeutics","volume":"33 1","pages":"e77-e78"},"PeriodicalIF":2.5,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145931807","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Omalizumab Treatment for Pregnancy With Refractory Acute Urticaria. Omalizumab治疗妊娠难治性急性荨麻疹。
IF 2.5 4区 医学 Q2 PHARMACOLOGY & PHARMACY Pub Date : 2026-01-01 DOI: 10.1097/MJT.0000000000001994
Qiancheng Deng, Yanyan Wu, Su Wang, Hong Fang, Jianjun Qiao
{"title":"Omalizumab Treatment for Pregnancy With Refractory Acute Urticaria.","authors":"Qiancheng Deng, Yanyan Wu, Su Wang, Hong Fang, Jianjun Qiao","doi":"10.1097/MJT.0000000000001994","DOIUrl":"https://doi.org/10.1097/MJT.0000000000001994","url":null,"abstract":"","PeriodicalId":7760,"journal":{"name":"American journal of therapeutics","volume":"33 1","pages":"e60-e62"},"PeriodicalIF":2.5,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145931853","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Obinutuzumab in Patients With Active Lupus Nephritis: A Meta-Analysis. Obinutuzumab治疗活动性狼疮性肾炎:荟萃分析
IF 2.5 4区 医学 Q2 PHARMACOLOGY & PHARMACY Pub Date : 2026-01-01 Epub Date: 2025-05-27 DOI: 10.1097/MJT.0000000000001988
Allahdad Khan, Shree Rath, Shaista Khadim, Zahid Ullah, Muhammad Junaid, Syed Ahtisham Halim, Asad Ali Ahmed Cheema
{"title":"Obinutuzumab in Patients With Active Lupus Nephritis: A Meta-Analysis.","authors":"Allahdad Khan, Shree Rath, Shaista Khadim, Zahid Ullah, Muhammad Junaid, Syed Ahtisham Halim, Asad Ali Ahmed Cheema","doi":"10.1097/MJT.0000000000001988","DOIUrl":"10.1097/MJT.0000000000001988","url":null,"abstract":"","PeriodicalId":7760,"journal":{"name":"American journal of therapeutics","volume":" ","pages":"e115-e118"},"PeriodicalIF":2.5,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144155561","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unveiling the Therapeutic Landscape of Salvia fruticosa: A Systematic Exploration of Pharmacology and Clinical Promise. 揭示鼠尾草的治疗景观:药理学和临床前景的系统探索。
IF 2.5 4区 医学 Q2 PHARMACOLOGY & PHARMACY Pub Date : 2026-01-01 Epub Date: 2025-09-29 DOI: 10.1097/MJT.0000000000001927
Fazil Ahmad
{"title":"Unveiling the Therapeutic Landscape of Salvia fruticosa: A Systematic Exploration of Pharmacology and Clinical Promise.","authors":"Fazil Ahmad","doi":"10.1097/MJT.0000000000001927","DOIUrl":"10.1097/MJT.0000000000001927","url":null,"abstract":"","PeriodicalId":7760,"journal":{"name":"American journal of therapeutics","volume":" ","pages":"e100-e101"},"PeriodicalIF":2.5,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145172276","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
American journal of therapeutics
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1